Pharmaceutical company Amneal Pharmaceuticals (NASDAQ:AMRX) reported Q4 CY2024 results , with sales up 18.4% year on year to ...
EPS: -$1.24 in Q4 vs. $3.93 in the same period last year ... opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by Andrew Mariathasan in New ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results